US Sternal Closure Systems News

Focus on Enhanced Closure Methods and Materials

The US sternal closure systems market continues to see developments focused on improving patient outcomes and reducing post-operative complications following open-heart surgery. Recent news highlights a growing interest in alternative closure methods to traditional stainless steel wires, as well as advancements in materials used.

Arthrex Study Highlights FiberTape Superiority: A recent clinical study published in the Journal of Clinical Medicine in early 2025 compared Arthrex's FiberTape® sternal closure system with traditional metal wires. The retrospective study of 300 patients demonstrated significant advantages for the FiberTape system, including reduced rates of sternal dehiscence and sternal wound infections. Patients in the FiberTape group also reported significantly less pain at 14 and 30 days post-surgery. Furthermore, the FiberTape system was associated with shorter closure times and eliminated the need for sternal protection adjuncts in obese patients, potentially leading to cost savings.

Rigid Sternal Fixation Gaining Traction: While traditional wire closure remains the dominant method in the US, a more orthopedic approach called Rigid Sternal Fixation, utilizing titanium plates, is slowly gaining adoption. This technique, long used in orthopedic surgery, aims to provide a more stable and anatomical repair of the divided sternum. Proponents, like surgeons at Franciscan Health, who use rigid fixation in all sternotomies, report faster patient recovery and a quicker return to normal activities. While only a small percentage of US cardiothoracic surgeons currently use this method, its benefits in terms of reduced complications and recovery time are becoming increasingly recognized. The primary barrier to wider adoption appears to be the initial cost of the plates, although some analysis suggests it can become cost-neutral within a few months due to fewer complications and reduced need for extended care.

New Products and Approvals: Companies continue to innovate in the sternal closure space. For instance, Able Medical Devices introduced looped wire sutures in early 2023, designed for more robust sternal closure with a doubled surface area compared to traditional wires. In late 2023, Abyrx received expanded FDA approval for its moldable bone putty, MONTAGE, for use in cardiothoracic surgery after sternotomy, potentially improving sternal repair and closure.

Market Growth and Trends: The US sternal closure systems market is experiencing steady growth, driven by an aging population, increasing incidences of cardiothoracic surgeries, and a focus on উন্নত post-operative outcomes. The market is seeing a trend towards materials like titanium due to its biocompatibility and non-ferromagnetic properties, allowing for safe MRI scans. Closure devices, as a product type, hold the largest market share due to benefits like reduced post-surgical complications and quicker recovery times compared to bone cement. Technological advancements, new product launches, and strategic mergers and acquisitions among key players are further shaping the market.

Overall: The US sternal closure systems market is evolving with a clear emphasis on উন্নত sternal stability, reduced complications, and faster patient recovery. While traditional wire closure remains prevalent, innovative technologies like rigid plate fixation and advanced suture materials are gaining recognition and demonstrating promising results in improving patient care following open-heart surgery.